We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery

By HospiMedica International staff writers
Posted on 14 Apr 2025

The heart's response to physical activity is a vital early indicator of changes in health, particularly in cardiovascular function and mortality. Extensive research has demonstrated a connection between abnormal heart-rate recovery (HRR) and several cardiovascular diseases, including heart failure, coronary artery disease, diabetes, hypertension, and sudden cardiac death. The amount of time it takes for the heart to return to its baseline rhythm after exercise can serve as a predictor for a range of cardiovascular or metabolic disorders. However, measuring HRR traditionally involves a complex process that requires the presence of a cardiologist, a treadmill, and other costly equipment and personnel. In a new study, scientists have utilized a “smart shirt” fitted with an electrocardiogram to track HRR after exercise and developed a tool to analyze the data, predicting the risk of heart-related ailments.

Researchers at the University of Illinois Urbana-Champaign (Champaign, IL, USA) set out to create a more accessible method for assessing and predicting cardiovascular risk. If a wearable device could collect relevant data as a person goes about their daily activities and send that information to a lab or doctor for analysis, it could make early diagnoses more accessible to a larger population. To accomplish this, the researchers leveraged a smart shirt developed by Carre Technologies (Quebec, Canada). The shirt contains sensors that continuously measure heart performance, including tracking heart-rate variability and electrical activity. The study involved 38 participants, aged between 20 and 76, who walked on a treadmill with varying speeds and inclines while wearing the device. The research was conducted in Illinois during the COVID-19 lockdown in 2021.

The researchers applied machine learning and other techniques to extract meaningful cardiac health signals from the collected data, designing a system to predict individuals at higher or lower risk of cardiovascular diseases. The team set a threshold of 28 beats per minute for median heart-rate recovery, classifying participants into high-risk and low-risk groups. Additional statistical measures were used to cross-verify the results. The study’s findings, published in the IEEE Journal of Health Informatics, show that the algorithm developed for the research provided reasonably accurate results, despite the small sample size, by aligning with different traditional classifiers and cross-validation approaches.

This study marks a significant first step in using wearable devices to help individuals assess their risk for heart-related issues more easily, potentially identifying concerning trends before they progress into serious disorders or lead to sudden death. The team envisions a system where data from wearables is collected and transmitted to a doctor’s office for interpretation. This would be particularly beneficial for those living in rural areas or places with limited access to advanced healthcare facilities. Future studies using wearable technology to predict cardiovascular risk should aim to involve a larger sample size, track participants over time, and compare their heart activity during both exercise and rest. Moreover, further research should focus on integrating this technology into standard healthcare practices.

“We want to use it to provide us with some greater insight in terms of our underlying cardiovascular function,” said Manuel Hernandez, a professor of biomedical and translational sciences at the Carle Illinois College of Medicine who led the research. “And we want to make something that’s clinically actionable.”

Related Links:
University of Illinois Urbana-Champaign
Carre Technologies

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Intelligent Mattress System
DualPlus
New
Dual-Screen Medical Display
C822W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.